Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
For your convenience, most scientific sessions are arranged by topics to suit your needs and interests & to allow you to compose your personal programme with your favourite sessions and presentations.
Acute heart failureAcute heart failure - diagnosis, pathophysiologyAcute heart failure - managementAcute heart failure - diuretics, fluid status and drug therapyAcute heart failure - prognosisAcute heart failure - other
Chronic heart failureChronic heart failure - diagnosis, pathophysiologyChronic heart failure - management Chronic heart failure - diuretics, fluid status and drug therapyChronic heart failure - prognosisChronic heart failure - other
Advanced heart failureArrhythmias and treatmentAtrial fibrillation
CardiomyopathyHypertrophic cardiomyopathyDilated cardiomyopathyCardiomyopathy (other)Hypertensive cardiomyopathyMyocarditis
Co-morbidities Cancer and anti-cancer drugs / Cardiotoxicity / CachexiaThe lungs ( COPD)Cardio-renal syndromeThe liverSkeletal muscleAnaemia and iron deficiencySleep disorder breathingCo morbodities (other)Cytokines and inflammationValvular heart disease(diagnosis, management and interventional therapies)
Devices / CRT / ICD / SurgeryCardiac resynchronisation therapyICDTelemedecine & remote patient managementAssist devicesOther devicesSurgeryBeta blockersRenin-angiotensin-aldosterone antagonistsHaemodynamics / Coronary and peripheral circulationHormones / Neurohumoral regulationMetabolism / Diabetes mellitus / Obesity
Heart failure imagingMRI, nuclear cardiology, CT, otherEchocardiography
BiomarkersBiomarkers (natriuretic peptides)Biomarkers (inflammation & oxidative stress)Biomarkers (prognosis)Biomarkers (other)
NursingPopulation studies / EpidemiologyPsychosocial / Ethical concepts / EducationExercise testing & trainingPulmonary hypertensionRight ventricular functionLeft ventricular functionHypertension / LV hypertrophy/ Renal denervationHFpEF - Heart failure with preserved ejection fractionAnimal models and experimentationCellular biologyCell signallingGene and cell therapyIschemia / Reperfusion / Preconditioning / PostconditioningMolecular biology / GeneticsVascular biology
© 2017 European Society of Cardiology. All rights reserved